Parthenon LLC’s AbbVie ABBV Stock Holding History

Parthenon LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.58M	Sell	14,215 -1,000	-7%	-$215K	0.37%	49
2026 Q1	$3.31M	Sell	15,215 -152	-1%	-$33.7K	0.38%	47
2025 Q4	$3.51M	Hold	15,367	–	–	0.38%	47
2025 Q3	$3.56M	Sell	15,367 -5,731	-27%	-$1.17M	0.39%	45
2025 Q2	$3.92M	Sell	21,098 -500	-2%	-$92.9K	0.45%	48
2025 Q1	$4.53M	Sell	21,598 -90	-0.4%	-$17.5K	0.56%	41
2024 Q4	$3.85M	Sell	21,688 -1,800	-8%	-$331K	0.47%	44
2024 Q3	$4.64M	Sell	23,488 -200	-0.8%	-$37.3K	0.55%	42
2024 Q2	$4.06M	Hold	23,688	–	–	0.52%	42
2024 Q1	$4.31M	Buy	23,688 +253	+1%	+$43.6K	0.55%	40
2023 Q4	$3.63M	Sell	23,435 -1,131	-5%	-$165K	0.5%	41
2023 Q3	$3.66M	Hold	24,566	–	–	0.55%	41
2023 Q2	$3.31M	Hold	24,566	–	–	0.48%	43
2023 Q1	$3.92M	Sell	24,566 -526	-2%	-$80.4K	0.6%	41
2022 Q4	$4.06M	Hold	25,092	–	–	0.67%	36
2022 Q3	$3.37M	Sell	25,092 -1,216	-5%	-$174K	0.61%	38
2022 Q2	$4.03M	Sell	26,308 -1,050	-4%	-$160K	0.68%	36
2022 Q1	$4.43M	Buy	27,358 +50	+0.2%	+$7.26K	0.64%	36
2021 Q4	$3.7M	Hold	27,308	–	–	0.52%	41
2021 Q3	$2.95M	Sell	27,308 -2,022	-7%	-$231K	0.44%	44
2021 Q2	$3.3M	Buy	29,330 +2,222	+8%	+$250K	0.5%	45
2021 Q1	$2.93M	Buy	27,108 +2,468	+10%	+$264K	0.47%	48
2020 Q4	$2.64M	Sell	24,640 -2,468	-9%	-$237K	0.46%	45
2020 Q3	$2.37M	Sell	27,108 -27	-0.1%	-$2.54K	0.46%	44
2020 Q2	$2.66M	Buy	27,135 +341	+1%	+$30K	0.55%	43
2020 Q1	$2.04M	Sell	26,794 -1,087	-4%	-$92.6K	0.49%	46
2019 Q4	$2.47M	Sell	27,881 -420	-1%	-$34.9K	0.49%	45
2019 Q3	$2.14M	Sell	28,301 -77	-0.3%	-$5.28K	0.46%	46
2019 Q2	$2.06M	Hold	28,378	–	–	0.44%	48
2019 Q1	$2.29M	Hold	28,378	–	–	0.51%	46
2018 Q4	$2.62M	Sell	28,378 -1,027	-3%	-$90.3K	0.64%	42
2018 Q3	$2.78M	Sell	29,405 -4,184	-12%	-$397K	0.61%	43
2018 Q2	$3.11M	Hold	33,589	–	–	0.72%	40
2018 Q1	$3.18M	Sell	33,589 -2,500	-7%	-$275K	0.75%	39
2017 Q4	$3.49M	Sell	36,089 -3,860	-10%	-$364K	0.79%	38
2017 Q3	$3.55M	Sell	39,949 -3,000	-7%	-$228K	0.84%	38
2017 Q2	$3.11M	Sell	42,949 -220	-0.5%	-$14.8K	0.74%	40
2017 Q1	$2.81M	Hold	43,169	–	–	0.67%	40
2016 Q4	$2.7M	Hold	43,169	–	–	0.66%	42
2016 Q3	$2.72M	Sell	43,169 -400	-0.9%	-$25.9K	0.68%	41
2016 Q2	$2.7M	Sell	43,569 -6,400	-13%	-$390K	0.68%	38
2016 Q1	$2.85M	Hold	49,969	–	–	0.73%	38
2015 Q4	$2.96M	Hold	49,969	–	–	0.77%	40
2015 Q3	$2.72M	Sell	49,969 -1,490	-3%	-$97K	0.76%	39
2015 Q2	$3.46M	Sell	51,459 -52	-0.1%	-$3.4K	0.91%	36
2015 Q1	$3.02M	Buy	51,511 +220	+0.4%	+$13.3K	0.8%	36
2014 Q4	$3.36M	Sell	51,291 -1,200	-2%	-$75.7K	0.93%	34
2014 Q3	$3.03M	Buy	52,491 +700	+1%	+$38.9K	0.88%	35
2014 Q2	$2.92M	Hold	51,791	–	–	0.86%	34
2014 Q1	$2.66M	Sell	51,791 -100	-0.2%	-$5.05K	0.8%	37
2013 Q4	$2.74M	Buy	51,891 +100	+0.2%	+$4.92K	0.84%	37
2013 Q3	$2.32M	Buy	51,791 +1,578	+3%	+$69.9K	0.77%	37
2013 Q2	$2.08M	Buy	+50,213	New	+$2.2M	0.7%	40

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Parthenon LLC's ABBV Position: Q2 2026 in Review

Parthenon LLC reduced its AbbVie (ABBV) stake by 6.6% in Q2 2026, selling an estimated $215K and leaving 14,215 shares worth $3.58M. The position accounts for 0.37% of the portfolio, ranked #49.

Parthenon LLC first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.64M in Q3 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Parthenon LLC held 14,215 shares of AbbVie worth $3.58M as of Q2 2026.
Parthenon LLC sold 1,000 AbbVie shares in Q2 2026, an estimated $215K.
AbbVie made up 0.37% of Parthenon LLC's portfolio in Q2 2026, its #49 holding.
Parthenon LLC first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Parthenon LLC's AbbVie position peaked at $4.64M in Q3 2024.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Parthenon LLC's 13F filing for Q2 2026, filed 23 Jul 2026.